MX348345B - Unidad de dosis, paquete de unidades de dosis e inhalador para inhalación de combinación de fármacos.. - Google Patents

Unidad de dosis, paquete de unidades de dosis e inhalador para inhalación de combinación de fármacos..

Info

Publication number
MX348345B
MX348345B MX2012000430A MX2012000430A MX348345B MX 348345 B MX348345 B MX 348345B MX 2012000430 A MX2012000430 A MX 2012000430A MX 2012000430 A MX2012000430 A MX 2012000430A MX 348345 B MX348345 B MX 348345B
Authority
MX
Mexico
Prior art keywords
dose
pockets
pack
inhalation
inhaler
Prior art date
Application number
MX2012000430A
Other languages
English (en)
Spanish (es)
Other versions
MX2012000430A (es
Inventor
Joseph Smith Ian
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of MX2012000430A publication Critical patent/MX2012000430A/es
Publication of MX348345B publication Critical patent/MX348345B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0003Details of inhalators; Constructional features thereof with means for dispensing more than one drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0031Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up by bursting or breaking the package, i.e. without cutting or piercing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0048Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0051Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0061Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using pre-packed dosages having an insert inside
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/06Containers or packages with special means for dispensing contents for dispensing powdered or granular material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mechanical Engineering (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Packages (AREA)
MX2012000430A 2009-07-07 2010-06-24 Unidad de dosis, paquete de unidades de dosis e inhalador para inhalación de combinación de fármacos.. MX348345B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22344109P 2009-07-07 2009-07-07
PCT/IB2010/052888 WO2011004287A1 (en) 2009-07-07 2010-06-24 Dose unit, pack of dose units and inhaler for inhalation of combination of drugs

Publications (2)

Publication Number Publication Date
MX2012000430A MX2012000430A (es) 2012-02-13
MX348345B true MX348345B (es) 2017-06-06

Family

ID=42732534

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012000430A MX348345B (es) 2009-07-07 2010-06-24 Unidad de dosis, paquete de unidades de dosis e inhalador para inhalación de combinación de fármacos..

Country Status (21)

Country Link
US (1) US9561336B2 (https=)
EP (1) EP2451514B1 (https=)
JP (1) JP5801997B2 (https=)
KR (1) KR101419141B1 (https=)
CN (1) CN102481424B (https=)
AR (1) AR077459A1 (https=)
AU (1) AU2010269899B2 (https=)
CA (1) CA2767306C (https=)
CY (1) CY1119441T1 (https=)
DK (1) DK2451514T3 (https=)
ES (1) ES2629833T3 (https=)
HU (1) HUE034595T2 (https=)
IL (1) IL217404A (https=)
MX (1) MX348345B (https=)
PL (1) PL2451514T3 (https=)
PT (1) PT2451514T (https=)
SG (1) SG177444A1 (https=)
SI (1) SI2451514T1 (https=)
TW (1) TWI561260B (https=)
WO (1) WO2011004287A1 (https=)
ZA (1) ZA201200221B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1844808A1 (de) * 2006-04-13 2007-10-17 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Medikamenten-Ausgabevorrichtung
JP6140143B2 (ja) 2011-03-21 2017-05-31 シムプリフィード ソリューションズ スウェーデン エービー 粉末形態の物質用の吸入器
AU2013202919C1 (en) * 2012-07-03 2016-02-04 Advent Pharmaceuticals Pty Ltd Blister Pack
SE537715C2 (sv) * 2013-11-26 2015-10-06 Simplified Solutions Sweden Ab Inhalationsanordning för ämnen i pulverform
CN105013054B (zh) * 2015-07-30 2018-11-09 中山市美捷时包装制品有限公司 一种多胶囊型干粉吸入装置
CN104984448B (zh) * 2015-07-30 2018-05-01 中山市美捷时包装制品有限公司 一种干粉吸入器
KR101992171B1 (ko) * 2017-06-27 2019-06-25 한국유나이티드제약 주식회사 건조분말 흡입기
US20200324064A1 (en) * 2019-04-10 2020-10-15 Cai Gu Huang Inhalation Device for Administering Powdered Pharmaceutical Composition
US12225935B2 (en) 2019-10-04 2025-02-18 Philip Morris Products S.A. Aerosol-generating devices
GB2589635B (en) * 2019-12-06 2021-12-01 Merxin Ltd Elongate form medicament carrier and medicament dispenser
DE112019007971A5 (de) * 2019-12-18 2022-09-22 Markus Mezger Inhalator
US20240139440A1 (en) * 2021-01-28 2024-05-02 Iconovo Ab Medicament packaging
EP4284474B1 (en) * 2021-01-28 2026-04-29 Iconovo AB Dry powder inhaler

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920839D0 (en) * 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
US6971383B2 (en) * 2001-01-24 2005-12-06 University Of North Carolina At Chapel Hill Dry powder inhaler devices, multi-dose dry powder drug packages, control systems, and associated methods
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
DE60230546D1 (de) 2001-10-26 2009-02-05 Pharmacia & Upjohn Co Llc Quaternäre ammoniumverbindungen und deren verwendung als antimuscarinische wirkstoffe
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
US7153903B1 (en) 2002-06-19 2006-12-26 The Board Of Regents Of The University Of Oklahoma Carbon nanotube-filled composites prepared by in-situ polymerization
GB0217196D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicament dispenser
EP1556034B1 (en) 2002-10-11 2008-04-16 Pfizer Limited Indole derivatives as beta-2 agonists
GB0315509D0 (en) 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
PT1708992E (pt) 2004-01-22 2007-11-16 Pfizer Derivados de sulfonamida para o tratamento de doenças
EP1708991B1 (en) 2004-01-22 2007-10-17 Pfizer Limited Sulfonamide derivatives for the treatment of diseases
EA200601510A1 (ru) 2004-03-17 2007-04-27 Пфайзер Инк. Производные фенилэтаноламина в качестве бета-2-агонистов
EP1730103B1 (en) 2004-03-23 2010-05-26 Pfizer Limited Formamide derivatives useful as adrenoceptor
SE0402976L (sv) * 2004-12-03 2006-06-04 Mederio Ag Medicinsk produkt
NZ585580A (en) 2005-07-18 2011-08-26 Pfizer Ltd Process for the preparation of sulfonamide derivatives
WO2007034325A1 (en) 2005-09-21 2007-03-29 Pfizer Limited Carboxamide derivatives as muscarinic receptor antagonists
RS20080411A (sr) 2006-03-20 2009-07-15 Pfizer Limited, Derivati amina
US20100160279A1 (en) 2006-09-22 2010-06-24 Pfizer Inc Azetidine Derivatives as Muscarinic Receptor Antagonists
AP2009004791A0 (en) 2006-10-04 2009-04-30 Pfizer Ltd Sulfonamide derivatives as adrenergic agonists andmuscarinic antagonists
WO2008056370A2 (en) * 2006-11-19 2008-05-15 Aespira Ltd. Dry-powder inhaler
EP1992380A1 (en) * 2007-05-16 2008-11-19 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device
PE20090136A1 (es) * 2007-06-01 2009-03-11 Boehringer Ingelheim Int Dispositivo dispensador
CA2699463A1 (en) 2007-09-14 2009-03-19 Pfizer Limited Novel compounds active as muscarinic receptor antagonists

Also Published As

Publication number Publication date
EP2451514A1 (en) 2012-05-16
AU2010269899B2 (en) 2013-06-13
JP2011015958A (ja) 2011-01-27
JP5801997B2 (ja) 2015-10-28
US9561336B2 (en) 2017-02-07
IL217404A0 (en) 2012-02-29
MX2012000430A (es) 2012-02-13
CA2767306C (en) 2014-05-20
KR101419141B1 (ko) 2014-07-11
CY1119441T1 (el) 2018-03-07
EP2451514B1 (en) 2017-04-26
ZA201200221B (en) 2013-03-27
SI2451514T1 (sl) 2017-07-31
HUE034595T2 (en) 2018-02-28
DK2451514T3 (en) 2017-07-03
CN102481424A (zh) 2012-05-30
AU2010269899A1 (en) 2012-02-02
US20120111327A1 (en) 2012-05-10
CA2767306A1 (en) 2011-01-13
WO2011004287A1 (en) 2011-01-13
PT2451514T (pt) 2017-06-21
SG177444A1 (en) 2012-02-28
CN102481424B (zh) 2014-05-07
KR20120042932A (ko) 2012-05-03
AR077459A1 (es) 2011-08-31
TW201106997A (en) 2011-03-01
TWI561260B (en) 2016-12-11
ES2629833T3 (es) 2017-08-16
IL217404A (en) 2014-12-31
PL2451514T3 (pl) 2017-09-29

Similar Documents

Publication Publication Date Title
MX348345B (es) Unidad de dosis, paquete de unidades de dosis e inhalador para inhalación de combinación de fármacos..
MY187036A (en) Inhalation device and method
EG25864A (en) Improvement of a dry powder inhaler
DK1173243T3 (da) Pulverinhalator til kombineret medikament
MX339902B (es) Inhalador.
BR112014014399A2 (pt) aparelho de aerolização para administração de medicamento independente do perfil de inalação
JP2016530030A5 (https=)
MX2014003186A (es) Formulaciones farmacéuticas resistentes a la manipulación.
EA201591869A1 (ru) Композиция, содержащая для повышения стабильности лекарственной формы по меньшей мере два сухих порошка, получаемых распылительной сушкой
MY184654A (en) Novel dosage form and formulation of abediterol
PH12014502619A1 (en) Novel dosage and formulation
TR200907917A2 (tr) Kuru toz inhaleri.
WO2009092591A8 (en) Inhaler
ZA202402174B (en) Dry powder medicament inhaler
ZA202203571B (en) Dry powder inhaler with an adherence monitor
WO2024167763A3 (en) Dual strip dry powder inhaler and manifolds for use therein
Boukhettala et al. D34 AEROSOLIZED MEDICATIONS: SPECIFICATIONS AND TREATMENT CONSIDERATIONS: Comparison Of The In Vitro Performances Of Two Valved Holding Chambers
RU2013106607A (ru) Способ лечения плевропульмональных осложнений у больных с острым панкреатитом
TH127533A (th) เครื่องแยกห่อยา

Legal Events

Date Code Title Description
FG Grant or registration